Status:
UNKNOWN
Effect of Intermittent Hepatic Inflow Occlusion During Donor Hepatectomy In Living Donor Liver Transplantation
Lead Sponsor:
Samsung Medical Center
Conditions:
End Stage Liver Disease
Living Donor
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Intermittent hepatic inflow occlusion (IHIO), also called Pringle maneuver, is a safe and effective procedure for major hepatectomy in patients with liver disease. In addition, ischemic preconditionin...
Detailed Description
Intermittent hepatic inflow occlusion (IHIO) by clamping of the portal triad, also called Pringle maneuver, is a safe and effective procedure in major hepatectomy in patients with liver disease. IHIO ...
Eligibility Criteria
Inclusion
- Donors and recipient of LDLT, saged ≥18 years, who will undergo LDLT with donors undergoing right hemihepatectomy and recipients receiving right hemiliver grafts
- Informed consent agreement
Exclusion
- if the recipients has fulminant hepatic failure
- if the graft to recipient body weight ratio (GRWR) is \<0.9
- if a frozen biopsy of the donor liver taken prior to donor hemihepatectomy shows \>30% macrovesicular steatosis
- if liver transplantation is ABO incompatible
- if recipients has received previous organ transplants
- if recipients has received or were scheduled to receive multi-organ transplants
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01171742
Start Date
July 1 2008
End Date
August 1 2010
Last Update
July 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710